148 related articles for article (PubMed ID: 18046428)
1. Analysis of factor VIII mediated suppression of lentiviral vector titres.
Radcliffe PA; Sion CJ; Wilkes FJ; Custard EJ; Beard GL; Kingsman SM; Mitrophanous KA
Gene Ther; 2008 Feb; 15(4):289-97. PubMed ID: 18046428
[TBL] [Abstract][Full Text] [Related]
2. Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter.
Picanço V; Heinz S; Bott D; Behrmann M; Covas DT; Seifried E; Tonn T
Cytotherapy; 2007; 9(8):785-94. PubMed ID: 17917890
[TBL] [Abstract][Full Text] [Related]
3. Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
Ikeda Y; Collins MK; Radcliffe PA; Mitrophanous KA; Takeuchi Y
Gene Ther; 2002 Jul; 9(14):932-8. PubMed ID: 12085241
[TBL] [Abstract][Full Text] [Related]
4. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA
Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice.
Connelly S; Andrews JL; Gallo-Penn AM; Tagliavacca L; Kaufman RJ; Kaleko M
Thromb Haemost; 1999 Feb; 81(2):234-9. PubMed ID: 10063998
[TBL] [Abstract][Full Text] [Related]
7. An engineered EBV vector expressing human factor VIII and von Willebrand factor in cultured B-cells.
Basu U; Banerjee S
J Gene Med; 2004 Jul; 6(7):760-8. PubMed ID: 15241783
[TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
[TBL] [Abstract][Full Text] [Related]
9. Stable gene transfer to the nervous system using a non-primate lentiviral vector.
Mitrophanous K; Yoon S; Rohll J; Patil D; Wilkes F; Kim V; Kingsman S; Kingsman A; Mazarakis N
Gene Ther; 1999 Nov; 6(11):1808-18. PubMed ID: 10602376
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.
Beutelspacher SC; Ardjomand N; Tan PH; Patton GS; Larkin DF; George AJ; McClure MO
Exp Eye Res; 2005 Jun; 80(6):787-94. PubMed ID: 15939034
[TBL] [Abstract][Full Text] [Related]
11. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
12. Long-term expression of von Willebrand Factor by a VSV-G pseudotyped lentivirus enhances the functional activity of secreted B-Domain-deleted Coagulation Factor VIII.
Park SW; Choi SY
Mol Cells; 2007 Aug; 24(1):125-31. PubMed ID: 17846507
[TBL] [Abstract][Full Text] [Related]
13. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
[TBL] [Abstract][Full Text] [Related]
14. Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.
O'Rourke JP; Olsen JC; Bunnell BA
Gene Ther; 2005 Jan; 12(1):22-9. PubMed ID: 15550928
[TBL] [Abstract][Full Text] [Related]
15. Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro.
Teng Q; Garrity-Moses M; Federici T; Tanase D; Liu JK; Mazarakis ND; Azzouz M; Walmsley LE; Carlton E; Boulis NM
Neurobiol Dis; 2005 Dec; 20(3):694-700. PubMed ID: 16005636
[TBL] [Abstract][Full Text] [Related]
16. In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac mice.
Bristol JA; Shirley P; Idamakanti N; Kaleko M; Connelly S
Mol Ther; 2000 Sep; 2(3):223-32. PubMed ID: 10985953
[TBL] [Abstract][Full Text] [Related]
17. Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A.
Zhang WW; Josephs SF; Zhou J; Fang X; Alemany R; Balagué C; Dai Y; Ayares D; Prokopenko E; Lou YC; Sethi E; Hubert-Leslie D; Kennedy M; Ruiz L; Rockow-Magnone S
Thromb Haemost; 1999 Aug; 82(2):562-71. PubMed ID: 10605752
[TBL] [Abstract][Full Text] [Related]
18. Protein trans-splicing based dual-vector delivery of the coagulation factor VIII gene.
Zhu F; Liu Z; Chi X; Qu H
Sci China Life Sci; 2010 Jun; 53(6):683-9. PubMed ID: 20602271
[TBL] [Abstract][Full Text] [Related]
19. Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptors.
Nicoud M; Kong J; Iqball S; Kan O; Naylor S; Gouras P; Allikmets R; Binley K
J Gene Med; 2007 Dec; 9(12):1015-23. PubMed ID: 17963276
[TBL] [Abstract][Full Text] [Related]
20. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
